West Pharma Execs Fuel Confidence with Phantom Stock Surge: Brutschea Buys 52 Units in Bullish Move
Janet Brutschea’s latest phantom stock purchase at West Pharmaceutical Services signals executive confidence in the company’s expansion and high‑growth injectable therapies, offering investors a bullish insider‑buying cue.
- West Pharmaceutical Services Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read